MOBILITY Trial Demonstrated Absolute Pro to be Safe and Effective in Patients with Peripheral Artery Disease in the Lower Extremities Abbott Park, Illinois — Abbott today announced that the U.S. Food ...
“The most common symptom is thigh or calf pain while walking, often described as a ‘Charley horse’ or muscle cramp. But many ...
Endologix LLC reported 12-month results from the second of two studies of a fully percutaneous, transmural arterial bypass therapy for treating peripheral arterial disease. Presented at this month's ...
Medical Device Network on MSN
Stryker agrees to acquire IVL developer Amplitude Vascular Systems
Amplitude Vascular’s lead development product is an intravascular lithotripsy platform for calcified peripheral artery ...
Having chronically cold feet isn't pleasant - neither for you nor for your partner when you snuggle up under the covers. Why do you have them? What could you do about them? You may suspect a ...
MARLBOROUGH, Mass., In an important clinical advancement in the treatment of peripheral artery disease (PAD), a key trial evaluating the Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
New research suggests a high-salt diet may trick the immune system into prematurely aging the blood vessels, leading to ...
Amplitude’s intravascular lithotripsy technology could emerge as a challenger to Shockwave IVL, Leerink Partners analyst Mike ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results